RU2010101054A - METHOD OF IMPACT ON THE IMMUNE SYSTEM - Google Patents

METHOD OF IMPACT ON THE IMMUNE SYSTEM Download PDF

Info

Publication number
RU2010101054A
RU2010101054A RU2010101054/15A RU2010101054A RU2010101054A RU 2010101054 A RU2010101054 A RU 2010101054A RU 2010101054/15 A RU2010101054/15 A RU 2010101054/15A RU 2010101054 A RU2010101054 A RU 2010101054A RU 2010101054 A RU2010101054 A RU 2010101054A
Authority
RU
Russia
Prior art keywords
immune system
impact
intravenously
influencing
lysine
Prior art date
Application number
RU2010101054/15A
Other languages
Russian (ru)
Inventor
Ирина Павловна Смирнова (RU)
Ирина Павловна Смирнова
Анна Александровна Шевченко (RU)
Анна Александровна Шевченко
Original Assignee
Ирина Павловна Смирнова (RU)
Ирина Павловна Смирнова
Анна Александровна Шевченко (RU)
Анна Александровна Шевченко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ирина Павловна Смирнова (RU), Ирина Павловна Смирнова, Анна Александровна Шевченко (RU), Анна Александровна Шевченко filed Critical Ирина Павловна Смирнова (RU)
Priority to RU2010101054/15A priority Critical patent/RU2010101054A/en
Publication of RU2010101054A publication Critical patent/RU2010101054A/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ воздействия на иммунную систему, включающий введение иммуногенного ферментного препарата, содержащего нативный и модифицированный ферменты L-лизин-α-оксидазы, полученные из культуры Trichoderma harzianum Rifai, внутривенно в терапевтической дозе 35 ЕД/кг ежедневно в течение 5 дней. A method of influencing the immune system, comprising administering an immunogenic enzyme preparation containing native and modified L-lysine-α-oxidase enzymes obtained from a Trichoderma harzianum Rifai culture, intravenously at a therapeutic dose of 35 U / kg daily for 5 days.

Claims (1)

Способ воздействия на иммунную систему, включающий введение иммуногенного ферментного препарата, содержащего нативный и модифицированный ферменты L-лизин-α-оксидазы, полученные из культуры Trichoderma harzianum Rifai, внутривенно в терапевтической дозе 35 ЕД/кг ежедневно в течение 5 дней. A method of influencing the immune system, comprising administering an immunogenic enzyme preparation containing native and modified L-lysine-α-oxidase enzymes obtained from a Trichoderma harzianum Rifai culture, intravenously at a therapeutic dose of 35 U / kg daily for 5 days.
RU2010101054/15A 2010-01-15 2010-01-15 METHOD OF IMPACT ON THE IMMUNE SYSTEM RU2010101054A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010101054/15A RU2010101054A (en) 2010-01-15 2010-01-15 METHOD OF IMPACT ON THE IMMUNE SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010101054/15A RU2010101054A (en) 2010-01-15 2010-01-15 METHOD OF IMPACT ON THE IMMUNE SYSTEM

Publications (1)

Publication Number Publication Date
RU2010101054A true RU2010101054A (en) 2011-07-20

Family

ID=44752216

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010101054/15A RU2010101054A (en) 2010-01-15 2010-01-15 METHOD OF IMPACT ON THE IMMUNE SYSTEM

Country Status (1)

Country Link
RU (1) RU2010101054A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465314C1 (en) * 2011-10-04 2012-10-27 Татьяна Ильинична Громовых Trichoderma harzianum m 99/51 micromycete strain used as producer for preparing biologically active anticancer preparations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465314C1 (en) * 2011-10-04 2012-10-27 Татьяна Ильинична Громовых Trichoderma harzianum m 99/51 micromycete strain used as producer for preparing biologically active anticancer preparations

Similar Documents

Publication Publication Date Title
PH12017501075B1 (en) Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
PH12015500243B1 (en) Glycoconjugation processes and compositions
EP3967323A3 (en) Hiv vaccine
GB201101665D0 (en) Immunogenic compositions
GEP20166442B (en) Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
SG11201806502UA (en) Conjugate of therapeutic enzymes
FR2938439B1 (en) EXTRACT OF AERIAL PARTS OF OATS HARVESTED BEFORE EPIAISON
MX2013001613A (en) Methods and compositions for preventing a condition.
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
GB2453475A (en) Live vaccine strains of francisella
EA201300132A1 (en) PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT AND PREVENTION OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
MX340626B (en) Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof.
AU2011280259A8 (en) Influenza vaccine
EA201300136A1 (en) DRUG AND METHOD OF PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS
BR112012019565A2 (en) polysaccharide-based antimicrobial formulations
UA118542C2 (en) Immunogenic compounds comprising hiv gp41 peptide coupled to crm197 carrier protein
WO2015051371A3 (en) Haemophilus parasuis vaccine serovar type four
MY193996A (en) Tripeptide compound, preparation method therefor, and application thereof
EA201590796A1 (en) FIBRINOLYTIC COMPOSITIONS, INCLUDING BROMELEIN AND NATTOKINAZ, FOR THE PREVENTION AND TREATMENT OF PHLEBOTHROMBOTIC CONDITIONS
SG10201901391RA (en) Induction of il-12 using immunotherapy
EP2579863A4 (en) Compounds for treatment of bovine mastitis
RU2010101054A (en) METHOD OF IMPACT ON THE IMMUNE SYSTEM
MX2022005086A (en) Immunomodulatory anti-cd73 antibodies and uses thereof.
MX2019003258A (en) Optimized synthetic consensus inmunogenic compositions targeting fibroblast activation protein.